THE ROLE OF SMARTPHONE GLUCOSE MONITORING APPS IN IMPROVING SELF-MANAGEMENT AMONG PATIENTS WITH TYPE 2 DIABETES
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5618Keywords:
Type 2 Diabetes Mellitus; Continuous Glucose Monitoring; Mobile Applications; Self-Care; Telemedicine; Glycemic Control; Patient Compliance; Digital Health TechnologiesAbstract
Type 2 diabetes remains one of the most common chronic diseases worldwide, and despite available treatment options, achieving optimal glycaemic control is still a challenge for many patients [1]. In recent years, the growing availability of smartphones and the development of continuous glucose monitoring (CGM) systems have created new opportunities to support daily self-management [6]. This narrative review aims to explore the role of smartphone-based glucose monitoring applications in the management of type 2 diabetes. The analysis is based on literature from PubMed and Google Scholar published between 2015 and 2026. The selected studies focused on the use of CGM systems integrated with mobile applications and their impact on clinical outcomes, patient adherence, and quality of life. The available evidence suggests that these technologies may improve glycaemic control, as reflected by reductions in HbA1c levels, increased time in range (TIR), and fewer episodes of hypo- and hyperglycaemia [14, 15]. In addition, they appear to support greater patient engagement and independence by providing real-time feedback and facilitating a better understanding of the relationship between lifestyle factors and glucose levels [6]. At the same time, several limitations need to be considered, including unequal access to technology and cost-related barriers [10]. Overall, smartphone-based CGM applications seem to be a valuable addition to standard diabetes care, although their effectiveness depends on proper implementation and long-term use.
References
GBD 2021 Diabetes Collaborators. (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 402(10397), 203–234. https://doi.org/10.1016/S0140-6736(23)01301-6
Park, J. H., Moon, J. H., Kim, H. J., Kong, M. H., & Oh, Y. H. (2020). Sedentary lifestyle: Overview of updated evidence of potential health risks. Korean Journal of Family Medicine, 41(6), 365–373. https://doi.org/10.4082/kjfm.20.0165
World Health Organization. (2022). Global status report on physical activity 2022.
Chinwong, D., Sukwuttichai, P., Jaiwong, N., Saenjum, C., Klinjun, N., & Chinwong, S. (2023). Smartphone use and addiction among pharmacy students in Northern Thailand: A cross-sectional study. Healthcare, 11(9), 1264. https://doi.org/10.3390/healthcare11091264
Adamczewska-Chmiel, K., Dudzic, K., Chmiela, T., & Gorzkowska, A. (2022). Smartphones, the epidemic of the 21st century: A possible source of addictions and neuropsychiatric consequences. International Journal of Environmental Research and Public Health, 19(9), 5152. https://doi.org/10.3390/ijerph19095152
Turner, J., & Stawarz, K. (2025). Understanding device integrations within diabetes apps: Mixed methods analysis of app features and user reviews. JMIR Diabetes, 10, e62926. https://doi.org/10.2196/62926
Hart, R. I., Kimbell, B., Rankin, D., Allen, J. M., Boughton, C. K., Campbell, F., de Beaufort, C., Fröhlich-Reiterer, E., Ware, J., Hofer, S. E., Kapellen, T. M., Rami-Merhar, B., Thankamony, A., Hovorka, R., Lawton, J., & KidsAP Consortium. (2022). Parents' experiences of using remote monitoring technology to manage type 1 diabetes in very young children during a clinical trial: Qualitative study. Diabetic Medicine, 39(7), e14828. https://doi.org/10.1111/dme.14828
American Diabetes Association Professional Practice Committee. (2024). 9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes—2024. Diabetes Care, 47(Suppl. 1), S158–S178. https://doi.org/10.2337/dc24-S009
Aleppo, G., & Webb, K. M. (2018). Integrated insulin pump and continuous glucose monitoring technology in diabetes care today: A perspective of real-life experience with the MiniMed™ 670G hybrid closed-loop system. Endocrine Practice, 24(7), 684–692. https://doi.org/10.4158/EP-2018-0097
Sabben, G., Telfort, C., Morales, M., Zhang, W. S., Espinoza, J. C., Pasquel, F. J., & Winskell, K. (2024). Technology and continuous glucose monitoring access, literacy, and use among patients at the diabetes center of an inner-city safety-net hospital: Mixed methods study. JMIR Diabetes, 9, e54223. https://doi.org/10.2196/54223
Costa, L. A. A., Furtado, B. A., Almeida, E. B., Callegari, B., Crisp, A. H., Chaves, R. O., Pinheiro, M. D. C. N., & Souza, G. S. (2025). E-waste for health: Recycling smartphones for health monitoring. Frontiers in Digital Health, 7, 1495408. https://doi.org/10.3389/fdgth.2025.1495408
Yang, C. C., Li, C. L., Yeh, T. F., & Chang, Y. C. (2022). Assessing older adults' intentions to use a smartphone: Using the meta-unified theory of the acceptance and use of technology. International Journal of Environmental Research and Public Health, 19(9), 5403. https://doi.org/10.3390/ijerph19095403
Yu, C. (2026). Application of AI and digital health tools in public health management of T2DM: From mechanism prediction to personalized treatment. Frontiers in Public Health, 14, 1756755. https://doi.org/10.3389/fpubh.2026.1756755
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., Davis, G., Kruger, D., Bhargava, A., Young, L., McGill, J. B., Aleppo, G., Nguyen, Q. T., Orozco, I., Biggs, W., . . . MOBILE Study Group. (2021). Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: A randomized clinical trial. JAMA, 325(22), 2262–2272. https://doi.org/10.1001/jama.2021.7444
Lian, X., Cheng, L. J., Teo, C. J. Y., Tan, I. J. S., Lim, H., Shen, L., Chew, J. H. S., Wang, W., & Dalan, R. (2026). Impact of real-time continuous glucose monitoring on glycaemic control in adults with type 2 diabetes: Systematic review and meta-analysis. Frontiers in Endocrinology, 16, 1761579. https://doi.org/10.3389/fendo.2025.1761579
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Stanisław Bajerski, Anna Maria Kowalska , Aleksandra Kuls, Aleksandra Zofia Sobol, Bogusław Pabis, Justyna Maria Wiktorowicz, Martyna Kadłubańska, Nicole Bulińska , Zofia Sinczak, Sonia Zembrzuska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
